Merck & Co., Inc.
MRKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
64,168
Cost of Revenue
15,193
Gross Profit
48,975
Gross Margin
76.3%
Operating Income
20,221
Operating Margin
31.5%
Net Income
17,117
Net Margin
26.7%
EPS (Basic)
$6.76
EPS (Diluted)
$6.74
EBITDA
25,706
EBITDA Margin
40.1%
2023
12/31/2023
Revenue
60,115
Cost of Revenue
16,126
Gross Profit
43,989
Gross Margin
73.2%
Operating Income
2,954
Operating Margin
4.9%
Net Income
365
Net Margin
0.6%
EPS (Basic)
$0.14
EPS (Diluted)
$0.14
EBITDA
6,907
EBITDA Margin
11.5%
2022
12/31/2022
Revenue
59,283
Cost of Revenue
17,411
Gross Profit
41,872
Gross Margin
70.6%
Operating Income
18,282
Operating Margin
30.8%
Net Income
14,519
Net Margin
24.5%
EPS (Basic)
$5.73
EPS (Diluted)
$5.71
EBITDA
21,315
EBITDA Margin
36.0%
2021
12/31/2021
Revenue
48,704
Cost of Revenue
13,626
Gross Profit
35,078
Gross Margin
72.0%
Operating Income
13,199
Operating Margin
27.1%
Net Income
13,049
Net Margin
26.8%
EPS (Basic)
$5.16
EPS (Diluted)
$5.14
EBITDA
17,899
EBITDA Margin
36.8%
2020
12/31/2020
Revenue
41,518
Cost of Revenue
13,618
Gross Profit
27,900
Gross Margin
67.2%
Operating Income
5,548
Operating Margin
13.4%
Net Income
7,067
Net Margin
17.0%
EPS (Basic)
$2.79
EPS (Diluted)
$2.78
EBITDA
10,180
EBITDA Margin
24.5%